| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Amylyx Pharmaceuticals, Inc. (AMLX) has 7 insiders with recent SEC Form 4 filings, including 6 buys and 20 sells. AMLX is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 3.32M | $51.99M | - | |
| CEO | 3.32M | $51.99M | - | |
| Dir | 812.9K | $12.74M | - | |
| CFO | 177.1K | $2.78M | - | |
| Other | 175.8K | $2.75M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 9, 2022 | Viking Global Investors LP66 | 10% Owner | Sell | 1,400,000 | $29.80 | $41,719,639.31 | -2.7% | +24.0% | -31.3% | |
| Jul 6, 2022 | Als Invest 1 B.V. | 10% Owner | Sell | 60,609 | $20.70 | $1,254,641.82 | -0.3% | +51.3% | -0.1% | |
| Jan 11, 2022 | Viking Global Investors LP66 | 10% Owner | Buy | 2,300,000 | $19.00 | $43,700,000.00 | New | -37.4% | +81.3% | |
| Jan 11, 2022 | Morningside Venture Investments Ltd93 | 10% Owner | Buy | 263,158 | $19.00 | $5,000,002.00 | +2.5% | -37.4% | +81.3% | |
| Jan 6, 2022 | Cheng Isaac | Director | Buy | 6,578 | $19.00 | $124,982.00 | New | -23.9% | +104.7% | |
| Jan 6, 2022 | Fonteyne Paul R. | Director | Buy | 3,947 | $19.00 | $74,993.00 | New | -23.9% | +104.7% | |
| Jan 6, 2022 | Milne George M Jr59 | Director | Buy | 26,315 | $19.00 | $499,985.00 | +13.5% | -23.9% | +104.7% | |
| Jan 6, 2022 | Olinger Margaret | Chief Commercial Officer | Buy | 6,842 | $19.00 | $129,998.00 | +3.3% | -23.9% | +104.7% |